90
Participants
Start Date
October 31, 2016
Primary Completion Date
December 4, 2017
Study Completion Date
December 11, 2017
Bupivacaine 0.25% with epinephrine
Bupivacaine 0.25% with epinephrine
National Cancer Institute, Cairo
Cairo University
OTHER